Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17566 | 593 | 50.7 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
262 | 3 | AUTOPHAGY//RESVERATROL//HISTONE DEACETYLASE INHIBITOR | 44558 |
1531 | 2 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE//HDAC INHIBITOR | 7464 |
17566 | 1 | TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC//HISTONE DEACETYLASE//SURG TRAUMA EMERGENCY SURG SURG CRIT C | 593 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC | address | 205967 | 1% | 100% | 4 |
2 | HISTONE DEACETYLASE | authKW | 189025 | 13% | 5% | 80 |
3 | SURG TRAUMA EMERGENCY SURG SURG CRIT C | address | 173437 | 1% | 42% | 8 |
4 | HISTONE DEACETYLASE INHIBITOR | authKW | 153515 | 11% | 5% | 65 |
5 | TRAUMA EMERGENCY SURG SURG CRIT CARE | address | 141728 | 4% | 11% | 25 |
6 | VALPROIC ACID | authKW | 141321 | 12% | 4% | 72 |
7 | TRICHOSTATIN A | authKW | 114398 | 6% | 6% | 36 |
8 | MOL NEUROBIOL SECT | address | 108039 | 3% | 11% | 19 |
9 | TRAUMA TRANSLAT CLIN | address | 102984 | 0% | 100% | 2 |
10 | HDAC INHIBITOR | authKW | 82624 | 6% | 4% | 36 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 752 | 22% | 0% | 133 |
2 | Immunology | 604 | 17% | 0% | 99 |
3 | Critical Care Medicine | 401 | 5% | 0% | 32 |
4 | Cell Biology | 394 | 15% | 0% | 88 |
5 | Medicine, Research & Experimental | 301 | 9% | 0% | 56 |
6 | Surgery | 198 | 12% | 0% | 70 |
7 | Rheumatology | 190 | 4% | 0% | 21 |
8 | Hematology | 157 | 6% | 0% | 34 |
9 | Biochemistry & Molecular Biology | 155 | 18% | 0% | 104 |
10 | Pharmacology & Pharmacy | 115 | 11% | 0% | 63 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC | 205967 | 1% | 100% | 4 |
2 | SURG TRAUMA EMERGENCY SURG SURG CRIT C | 173437 | 1% | 42% | 8 |
3 | TRAUMA EMERGENCY SURG SURG CRIT CARE | 141728 | 4% | 11% | 25 |
4 | MOL NEUROBIOL SECT | 108039 | 3% | 11% | 19 |
5 | TRAUMA TRANSLAT CLIN | 102984 | 0% | 100% | 2 |
6 | ANIM BOSCI | 51492 | 0% | 100% | 1 |
7 | BIOSCI LN BIO | 51492 | 0% | 100% | 1 |
8 | CELL AUTOANTIBODY B | 51492 | 0% | 100% | 1 |
9 | CLIN TRANSLAT SHANGHAISHANGHAI | 51492 | 0% | 100% | 1 |
10 | ENDOCRINOL DIABET METABPERELMAN MED | 51492 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF TRAUMA AND ACUTE CARE SURGERY | 5530 | 3% | 1% | 15 |
2 | MOLECULAR MEDICINE | 4008 | 2% | 1% | 11 |
3 | NEUROTHERAPEUTICS | 1883 | 1% | 1% | 5 |
4 | SURGERY | 1145 | 3% | 0% | 15 |
5 | EPIGENOMICS | 997 | 1% | 1% | 3 |
6 | JOURNAL OF SURGICAL RESEARCH | 946 | 2% | 0% | 14 |
7 | NEUROMOLECULAR MEDICINE | 825 | 1% | 1% | 3 |
8 | IMMUNOLOGY AND CELL BIOLOGY | 799 | 1% | 0% | 6 |
9 | INTERNATIONAL IMMUNOPHARMACOLOGY | 749 | 1% | 0% | 8 |
10 | IMMUNOBIOLOGY | 574 | 1% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DINARELLO, CA , FOSSATI, G , MASCAGNI, P , (2011) HISTONE DEACETYLASE INHIBITORS FOR TREATING A SPECTRUM OF DISEASES NOT RELATED TO CANCER.MOLECULAR MEDICINE. VOL. 17. ISSUE 5-6. P. 333 -352 | 60 | 37% | 61 |
2 | CHEN, S , WU, HJ , KLEBE, D , HONG, Y , ZHANG, JM , (2014) VALPROIC ACID: A NEW CANDIDATE OF THERAPEUTIC APPLICATION FOR THE ACUTE CENTRAL NERVOUS SYSTEM INJURIES.NEUROCHEMICAL RESEARCH. VOL. 39. ISSUE 9. P. 1621 -1633 | 39 | 41% | 15 |
3 | HANCOCK, WW , AKIMOVA, T , BEIER, UH , LIU, YJ , WANG, LQ , (2012) HDAC INHIBITOR THERAPY IN AUTOIMMUNITY AND TRANSPLANTATION.ANNALS OF THE RHEUMATIC DISEASES. VOL. 71. ISSUE . P. 46-54 | 47 | 32% | 24 |
4 | HALILI, MA , ANDREWS, MR , SWEET, MJ , FAIRLIE, DP , (2009) HISTONE DEACETYLASE INHIBITORS IN INFLAMMATORY DISEASE.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 3. P. 309-319 | 39 | 38% | 77 |
5 | HALAWEISH, I , NIKOLIAN, V , GEORGOFF, P , LI, YQ , ALAM, HB , (2015) CREATING A "PROSURVIVAL PHENOTYPE" THROUGH HISTONE DEACETYLASE INHIBITION: PAST, PRESENT, AND FUTURE.SHOCK. VOL. 44. ISSUE . P. 6 -16 | 37 | 39% | 3 |
6 | CIARLO, E , SAVVA, A , ROGER, T , (2013) EPIGENETICS IN SEPSIS: TARGETING HISTONE DEACETYLASES.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 42. ISSUE . P. S8-S12 | 24 | 62% | 9 |
7 | GRABIEC, AM , TAK, PP , REEDQUIST, KA , (2011) FUNCTION OF HISTONE DEACETYLASE INHIBITORS IN INFLAMMATION.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 31. ISSUE 3. P. 233 -263 | 49 | 29% | 35 |
8 | NELSON, DW , PORTA, CR , MCVAY, DP , SALGAR, SK , MARTIN, MJ , (2013) EFFECTS OF HISTONE DEACETYLASE INHIBITION ON 24-HOUR SURVIVAL AND END-ORGAN INJURY IN A PORCINE TRAUMA MODEL: A PROSPECTIVE, RANDOMIZED TRIAL.JOURNAL OF TRAUMA AND ACUTE CARE SURGERY. VOL. 75. ISSUE 6. P. 1031-1039 | 18 | 78% | 4 |
9 | LEUS, NGJ , ZWINDERMAN, MRH , DEKKER, FJ , (2016) HISTONE DEACETYLASE 3 (HDAC 3) AS EMERGING DRUG TARGET IN NF-KAPPA B-MEDIATED INFLAMMATION.CURRENT OPINION IN CHEMICAL BIOLOGY. VOL. 33. ISSUE . P. 160 -168 | 31 | 37% | 2 |
10 | LOHMAN, RJ , IYER, A , FAIRLIE, TJ , COTTERELL, A , GUPTA, P , REID, RC , VESEY, DA , SWEET, MJ , FAIRLIE, DP , (2016) DIFFERENTIAL ANTI-INFLAMMATORY ACTIVITY OF HDAC INHIBITORS IN HUMAN MACROPHAGES AND RAT ARTHRITIS.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 356. ISSUE 2. P. 387 -396 | 23 | 43% | 4 |
Classes with closest relation at Level 1 |